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ABSTRACT
The assignment of cognate odorant/agonist pairs is a prerequisite for an understanding of odorant coding at the receptor 
level. However, the identification of new ligands for odorant receptors (ORs) in cell-based assays has been challenging, 
due to their individual and rather sub-optimal plasma membrane expression, as compared with other G protein-cou-
pled receptors. Accessory proteins, such as the chaperone RTP1S, or Ric8b, have improved the surface expression 
of at least a portion of ORs. Typically, recombinant ORs carry N-terminal tags, which proved helpful for their functional 
membrane expression. The most common tag is the ‘Rho-tag’, representing an N-terminal part of rhodopsin, but also 
‘Lucy-’ or ‘Flag-tag’ extensions have been described. Here, we used a bi-functional N-terminal tag, called ‘interleukin 6 
(IL-6)-HaloTag®’, with IL-6 facilitating functional cell surface expression of recombinant ORs, and the HaloTag® protein, 
serving as a highly specific acceptor for cell-impermeant or cell-permeant, fluorophore-coupled ligands, which enable 
the quantification of odorant receptor expression by live-cell flow cytometry. Our experiments revealed on average an 
about four-fold increased surface expression, a four-fold higher signaling amplitude, and a significantly higher potency 
of odorant-induced cAMP signaling of six different human IL-6-HaloTag®-ORs across five different receptor families 
in NxG 108CC15 cells, as compared to their Rho-tag–HaloTag® constructs. We observed similar results in HEK-293 
cells. Moreover, screening an IL-6–HaloTag®-odorant receptor library with allyl phenyl acetate, revealed both known 
receptors as best responders for this compound. In summary, the IL-6–HaloTag® represents a promising tool for the 
de-orphaning of ORs.
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INTRODUCTION
Odorant receptors (ORs) are seven transmembrane domain G-pro-
tein coupled receptors (GPCRs), which are the molecular basis for our 
sense of smell. Already identified in 1991 [1], the majority (85%) of the 
ca. 400 different human OR types have no assigned cognate agonists, 
yet. This is based on a sub-optimal plasma membrane expression of 
recombinant ORs in heterologous cell systems. ORs may be retained in 
the endoplasmic reticulum (ER), or are post-translationally modified, 
and so targeted for degradation [2,3]. Moreover, ORs are prone to 
be affected by single nucleotide polymorphisms (SNPs), which may 
alter ligand binding, signaling, or trafficking to the plasma membrane 
[4-6]. Beyond measuring their functional expression, it is therefore 
inevitable to investigate also the plasma membrane expression of ORs 
and their genetic variants. Research on intracellular OR trafficking 
focused primarily on the role of forward trafficking proteins [3]. These 
include accessory proteins such as receptor-transporting protein 1 
(RTP1), or RTP1S, RTP2, receptor expression-enhancing protein 1 
(REEP1) [7,8], and the guanine nucleotide exchange factor Ric8b [9], 
which enhanced the cell surface expression of recombinant ORs in 
test cell systems without altering their ligand specificity [10]. Still, an 
enhanced cell surface expression often requires a modification of the 
OR itself: it is, therefore, common to fuse the receptor’s N-terminus 
with a protein ‘tag’. Such epitope tags are short peptide sequences with 
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useful characteristics. First, high-affinity antibodies and/or chemical 
labels [11] are usually available for tags, which enable the detection 
and visualization of recombinant protein in experimental setups such 
as western blotting, immunocytochemistry, or immunoprecipitation. 
Common tags are, for example, FLAG-tag [12] or His-tag [13]. Sec-
ond, N- or C-terminal tags may facilitate the cell-surface expression 
of recombinant membrane proteins in heterologous cell systems. For 
ORs, several tags have been used to improve their sub-optimal plasma 
membrane expression. Initially, the addition of the first 20 amino acids 
of bovine rhodopsin to the N-terminus of ORs, called Rho-tag, were 
shown to enable the surface expression of ORs in test cell systems [14]. 
This Rho-tag, or an extended version, comprising the entire N-terminus 
of rhodopsin, has been validated to facilitate cell surface expression of 
recombinant ORs by several groups independently, and for a variety of 
chemosensory odorant and taste receptors [10,15-18], and today is the 
most commonly used N-terminal tag for recombinant ORs, but also for 
taste receptors. Shepard et al. [19] investigated a leucine-rich 17-amino 
acid cleavable signal peptide (LRRC32), which they named “Lucy”. 
Further, they combined Lucy-tag with Rho-tag and could show, that the 
combination of Lucy-tag with Rho-tag increased the surface expression 
of all investigated ORs in their study [19].
In this study, we used a bi-functional N-terminal tag, that consists 
of two parts, interleukin 6 (IL-6) and a modified bacterial haloalkane 
dehalogenase, the HaloTag®, which can be recognized by several cell-im-
permeant or cell-permeant fluorophore-coupled ligands [20,21]. The 
HaloTag® technology comprises the HaloTag® protein and a variety of 
organic molecules, the HaloTag® ligands, which irreversibly bind to 
the HaloTag® protein. Under physiological conditions, this covalent 
bond forms rapidly and is highly specific. The HaloTag® protein is a 
33 kDa monomeric protein that does not occur naturally in mammals, 
plants, or E. coli. Therefore, its nonspecific activity is extremely low 
[20,21]. IL-6 is a secreted protein (~25 kDa) of the immune system. 
It belongs to the group of pro-inflammatory cytokines and plays a key 
role in the unspecific, innate immune response. Synthesis and release 
of IL-6 are initiated by the binding of foreign antigens to the receptors 
of the innate immunity, and appear within few hours after the activation 
of the cellular immune system [22].
Here we compared several IL-6-HaloTag®-OR constructs with 
known agonists with their Rho-tag-HaloTag® constructs with respect 
to their functional plasma membrane expression in NxG 108CC15 and 
HEK-293 cells. To evaluate their screening performance and concen-
tration-response relations we used the fast, online luminescence-based 
GloSensor® cAMP assay [15,23]. We assessed the plasma membrane 
expression of all OR constructs by live-cell staining with a cell-imper-
meable, fluorophore-coupled HaloTag® ligand, and subsequent analysis 
by flow cytometry.
METHODS
Chemicals
The following chemicals were used: Dulbecco’s MEM medium (#F0435), 
FBS superior (#S0615), L-glutamine (#K0282), penicillin (100U/ml)/
streptomycin (100U/ml) (#A2212), trypsin/EDTA solution (#L2143) (Bio-
chrom, Berlin, Germany), MEM non-essential amino acid solution (100x) 
(#M7145, Sigma-Aldrich, Steinheim, Germany), Gibco® HAT supple-
ment (#21060-017, Thermo Fisher, Dreieich, Germany),CaCl2*2H2O 
(#22322.295), D-glucose (#101174Y), dimethyl sulfoxide (DMSO) 
(#83673.230), HEPES (#441476L), potassium chloride (#26764.230), 
and sodium hydroxide (#28244.295) (VWR Chemicals BDH Prolabo, 
Leuven, Belgium), sodium chloride (#1064041000, Merck, Darmstadt, 
Germany), D-luciferin (beetle) monosodium salt (#E464X), HaloTag® 
Alexa Fluor® 488 Ligand (#G1001, Promega, Madison, USA), Dyna-
sore (#2897, Tocris Bioscience, Bristol, UK), Hoechst33342 (#1399, 
Invitrogen, Eugene, USA), Mowiol 4-88 (#0713, Carl Roth GmbH + 
Co. KG, Karlsruhe, Germany) , Paraformaldehyde (PFA) (#18814, 
Polysciences Inc., Warrington, USA).
Odorants were purchased from Sigma-Aldrich (Steinheim, Germany), 
Alfa-Aesar (Karlsruhe, Germany) and Chemos GmbH (Regenstauf, 
Germany) (Table S1).
Molecular cloning
The protein-coding regions (NCBI reference sequence, Table S2) 
of human OR1A1, OR2M3, OR2W1, OR8D1, OR10J5, OR51E1 and 
mouse Olfr16 were amplified from genomic DNA with gene specific 
primers (Table S3) by polymerase chain reaction (PCR).
PCR reactions with a final volume of 50 µl were performed in a 
C-1000 thermocycler (BioRad, Muenchen, Germany) with 150 ng of 
respective genomic DNA, 0.5 µl Phusion hot start DNA-polymerase 
(#F-534L), 1.5 µl DMSO (#F-515, Thermo Scientific, Waltham, USA), 
2.5 mmol/L dNTPs (#U1511, Promega, Madison, USA), and 0.5 µmol/L 
of each primer. The following protocol was used: denaturation (98°C, 
3 min), followed by 10 cycles containing: denaturation (98°C, 30 s), 
annealing with 1°C decreasing in temperature each cycle (start 66°C, 
30 s), extension (72°C, 2 min); 30 cycles containing: denaturation 
(98°C, 30 s), annealing (58°C, 30 s), extension (72°C, 2 min) and final 
elongation (72°C, 10 min).
PCR products were purified (gel extraction kit, #28706, Qiagen, 
Hilden, Germany), digested either EcoRI/NotI (#R6017/ #R6435, 
Promega, Madison, USA) or MfeI/NotI (#R0589S/ #R0189S, New 
England Biolabs, Ipswich, USA) and ligated with T4 DNA ligase 
(#M1804, Promega, Madison, USA) into the expression plasmid pF-
N210A (#pFN210A SS-HaloTag® CMV-neo Flexi®-Vector, Promega, 
Madison, USA).
Plasmid-DNA was transformed by heat shock in competent E. coli 
XL-1-blue cells (#200249, Agilent Technologies, Santa Clara, USA) 
and purified with pure yield plasmid midiprep kit (#A2495, Promega, 
Madison, USA). Plasmid-DNA concentration was determined with 
the Nanodrop 2000 (Thermo Fisher Scientific, Waltham, USA) and 
adjusted to 250 ng/µl.
Sequencing
All sub-cloned wild-type (wt.) and mutated OR-coding amplicons 
were verified by Sanger sequencing (Eurofins Genomics, Ebersberg, 
Germany) by using vector internal primers (Table S4).
Cell culture and transient DNA transfection
We used a neuroblastoma x glioma hybrid (NxG 108CC15 cells), 
and a human embryonic kidney (HEK-293 cells) cell line, as test 
cell systems for the functional expression of recombinant ORs as 
described previously [15]. The transfection was performed by using 
the lipofection method with either the IL-6-HaloTag®-OR or the Rho-
HaloTag®-OR constructs. The transport protein RTP1S [7], G protein 
subunit Gαolf [24,25], olfactory G protein subunit Gγ13 [26] and the 
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GloSensorTM-22F [23] (Promega, Madison, USA) were co-transfected 
using Lipofectamine® 2000 (#11668-027, Life Technologies, USA). The 
pGloSensorTM-22F is a genetically engineered luciferase with a cAMP 
binding pocket, which allows measuring a direct cAMP dependent 
luminescence signal. As a negative control, we transfected the vector 
plasmid pFN210A lacking any OR coding region, together with Gαolf, 
RTP1S, Gγ13 and cAMP-luciferase pGloSensorTM-22F (mock). The 
amount of transfected plasmid-DNA was equal in OR-transfected and 
mock-transfected cells.
cAMP luminescence assay
The cAMP luminescence assays were performed 42 h post transfection 
as reported previously [15]. The cells were incubated with a physiological 
salt buffer (pH 7.5) containing 140 mmol/L NaCl, 10 mmol/L HEPES, 
5 mmol/L KCl, 1 mmol/L CaCl2, 10 mmol/L D-glucose and 2% D-lu-
ciferin. For the cAMP luminescence measurements, the Glomax® 
MULTI+ detection system (Promega, Madison, USA) was used. After 
an incubation of the cells for 1 h in the dark, the basal luminescence 
signal of each well was recorded. Odorant stock solutions were prepared 
in DMSO and diluted 1:1000 in the physiological salt buffer to obtain 
a final DMSO concentration of 0.1% DMSO on the cells. Real-time 
luminescence signals for each well were measured 4 min after the 
odorant application.
Data analysis of cAMP luminescence measurements
The raw luminescence data obtained from the Glomax® MULTI+ 
detection system were analyzed using Instinct Software (Promega, USA). 
Three data points before (baseline) and after odorant addition (signal) 
were averaged, and the respective baseline value was subtracted from 
each signal. For screening experiments, a single experiment was per-
formed and two data points were averaged. The signals were normalized 
by the highest luciferase ratio and a 3σ-threshold was calculated. All 
signals above the 3σ-threshold (mean + 3 standard deviations over all 
signals) were assessed as positive signals. For concentration-response 
relations, the baseline-corrected dataset was normalized to the maxi-
mum amplitude of each odorant-receptor pair. EC50 values and curves 
were derived from fitting the function f(x) = ((min−max)/(1 + (x/EC50)
hillslope)) + max to the data by nonlinear regression (SigmaPlot 10.0, 
Systat Software). All data are presented as mean ± SD.
Flow cytometry
NxG 108CC15 cells [27] were cultivated in 12-well plates (80000 
cells/well) and transiently transfected with 800 ng plasmid-DNA of 
the respective OR as well as 400 ng plasmid-DNA of Gαolf, Gγ13, 
RTP1S and cAMP-luciferase pGloSensorTM-22F each using Lipofect-
amine® 2000. To keep the amount of transfected DNA compared to cell 
number the same as in the luminescence assay, we also transfected the 
cAMP-luciferase pGloSensorTM-22F, although it has no impact on cell 
surface expression of the respective OR. Basically, the experimental 
settings were scaled up 8-fold from the 96-well luminescence assay to 
the 12-well flow cytometry assay. As a control, the transfection was 
performed with the vector plasmid pFN210K which is lacking the 
coding information of the HaloTag® (mock control).
For analysis, cells were harvested 42 h post transfection and stained 
with the cell-impermeant HaloTag® Alexa Fluor® 488 Ligand (ex/em 
= 499/518 nm). Cells were incubated for 1 h at 37°C and 7% CO2 in 
the cell culture incubator. Cells were washed twice with serum free 
medium prior to FACS analyses (MACSQuant Analyzer, Miltenyi 
Biotec, Bergisch Gladbach, Germany). A forward- and side-scatter gate 
was set to exclude dead cells with forward-scatter (FSC: 235V) and 
side-scatter (SSC: 360V). The FITC signal (B1-channel; HaloTag® Alexa 
Fluor488 Ligand) was detected with 175V. In each case 10000 cells 
were measured. The analysis was performed with the MACSQuantify 
software (Miltenyi Biotec, Bergisch Gladbach, Germany). The FITC 
signal of each mock control (AlexaFluor488 treated cells) defined the 
distinction between negative and positive cells.
Membrane-impermeable fluorescence labeling of cell 
surface HaloTag® ORs
NxG 108CC15 cells [27] were cultivated in 6-well plates (300000 
cells/well) and transiently transfected with 3000 ng plasmid-DNA of 
the respective OR as well as 1500 ng plasmid-DNA of Gαolf, Gγ13, 
RTP1S and cAMP-luciferase pGloSensorTM-22F each using Lipofect-
amine® 2000. To keep the amount of transfected DNA compared to cell 
number the same as in the luminescence assay, we also transfected the 
cAMP-luciferase pGloSensorTM-22F, although it has no impact on cell 
surface expression of the respective OR. As a control, the transfection 
was performed with the vector plasmid pFN210K which is lacking the 
coding information of the HaloTag® (mock control).
For analysis, 40 h post transfection cells were incubated with or 
without 80 µM Dynasore in DMSO for 30 min at 37°C and 7% CO2. 
Throughout the following steps the concentrations of Dynasore and/
or DMSO were kept constant. Cells were washed once and harvested. 
After centrifugation the cells were incubated with the cell-impermeant 
HaloTag® Alexa Fluor® 488 Ligand (ex/em = 499/518 nm) for 1 h at 
37°C and 7% CO2. Cells were washed once with serum free medium 
and stained with Hoechst33342 (1:1000) for 7 min in the dark. After 
centrifugation the cells were fixed with 2% PFA for 15 min at RT. 
The cells were washed again, divided in half, and centrifuged. For 
FACS analyses, cells were re-suspended in serum free medium, and 
for confocal microscopy, cells were re-suspended in Mowiol 4-88, and 
transferred to a cover slip.
Fluorescence confocal microscopy was performed on a laser-equipped, 
inverted Olympus FV1000 microscope with an Olympus UPlanSApo 
60x/w objective.
RESULTS
In 2015, we introduced the fast, online GloSensorTM [23] technology 
as a useful tool for the sensitive detection of odorant/receptor-induced 
cAMP signaling in recombinant test cell systems, such as HEK-293 or 
NxG 108CC15 cells [15]. Since then, we and others have successfully 
used the GloSensorTM cAMP assay for the de-orphaning and functional 
characterization of ORs in recombinant test cell systems [6,15,17,28]. In 
the present study, we used NxG 108CC15 cells, which actually express 
RNA for olfactory adenylyl cyclase (AC) type III, as well as for four 
other ACs (Table S5, Fig. S1, [15]), together with the GloSensorTM 
assay, to measure the function of seven ORs and one non-olfactory 
GPCR, carrying different N-terminal tags.
Different N-terminal epitope tags have a profound influ-
ence on the ligand specificity of ORs
It was commonly observed that the use of the Rho-tag [14] as 
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N-terminal epitope tag for ORs enhances their cell-surface expression 
[14,18]. Here we used another tag, called HaloTag® combined with IL-6 
(IL-6-HaloTag®) and compared the function of well-known, de-orphaned 
ORs carrying this tag with ORs carrying the HaloTag® combined with 
Rho-tag (Rho-tag-HaloTag®), but also with ORs carrying just the Rho-tag.
Therefore we established concentration-response-relations for six 
ORs of different families, one OR of mice as well as dopamine receptor 
D
1
 (DRD1).
We could observe for all tested receptors, which were tagged with IL-
6-HaloTag®, lower EC50 values as well as higher amplitudes, as compared 
to their corresponding Rho-tag-HaloTag® constructs (Fig. 1, Table 1). 
Moreover, ORs carrying the IL-6-HaloTag® in general outperformed 
ORs carrying just the Rho-tag (Fig. S2), with the exception of OR2M3, 
where the Rho-tagged receptor outperformed all other tags (Fig. S2C).
Figure 1. Concentration-response relations for selected odorant/OR combinations with different N-terminal tags in NxG 108CC15 cells. A. 
Schemes of receptor constructs, carrying either IL-6-HaloTag® or Rho-tag-HaloTag®. B. OR1A1 with (R)-(-)-carvone. C. OR2M3 with 3-mercapto-2-meth-
ylpentan-1-ol. D. OR2W1 with allyl phenyl acetate. E. OR8D1 with sotolone. F. OR10J5 with lyral. G. OR51E1 with butyric acid. H. Olfr16 with lyral [29]. 
I. DRD1 with dopamine. EC50 values (Table 1) were derived from fitting a function to concentration-response data by means of non-linear regression. 
Shown are mean ± SD (n = 3–5). Data were normalized to each receptor’s maximum amplitude with the N-terminal tag IL-6-HaloTag®. Red colored 
curves indicate receptors with the N-terminal tag IL-6-HaloTag®, blue with Rho-tag-HaloTag®, and black curves indicate the empty plasmid control (Mock).
Further, we compared the above investigated receptors also in HEK-
293 cells. Here we screened the receptors, which were equipped with 
different epitope tags, with the same, single concentration of their re-
ported agonist, and compared their normalized response amplitudes. We 
observed higher amplitudes across the investigated receptors carrying 
the new epitope tag IL-6-HaloTag®, as compared to their Rho-tag-
HaloTag® constructs (Fig. 2).
HaloTag® technology enables the live-cell cell-surface staining and 
flow cytometry, and intracellular monitoring of labeled receptors
It has been repeatedly observed that different OR types do not express 
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equally well at the plasma membrane in recombinant test cell systems. 
For receptors carrying the HaloTag®, however, we were able to measure 
the cell-surface expression of ORs via flow cytometry. We investigated 
six human ORs, one mouse OR and DRD1 by labeling the HaloTag® 
with a cell-impermeant ligand (HaloTag® Alexa Fluor® 488 Ligand). 
We observed, that all tested receptors carrying the IL-6-HaloTag®, 
showed a higher cell-surface expression than their Rho-tag-HaloTag® 
constructs (Fig. 3, Table 1).
Figure 2. Normalized efficacies of receptors carrying the epitope tags IL-6-HaloTag® or Rho-tag-HaloTag® in HEK-293 cells. A. Shown are the 
normalized amplitudes of receptors carrying either the IL-6-HaloTag® (red bars) or the Rho-tag-HaloTag® (blue bars), when challenged with their report-
ed agonist: OR1A1 with (R)-(-)-carvone (1000 µM); OR2M3 with 3-mercapto-2-methylpentan-1-ol (60 µM); OR2W1 with allyl phenyl acetate (300 µM); 
OR8D1 with sotolone (300 µM); OR10J5 with lyral (300 µM); OR51E1 with butyric acid (300 µM); Olfr16 with lyral (300 µM); and DRD1 with dopamine 
(10 nM). Shown are means ± SD (n = 3). Data were normalized to each receptor’s maximum amplitude with the N-terminal tag IL-6-HaloTag®. Mock, 
empty plasmid control (black bars). B. Shown are differences in odorant responses averaged over all tested ORs carrying either the IL-6-HaloTag® (red 
bar) or the Rho-tag-HaloTag® (blue bar).
Table 1. EC50 values, efficacies and membrane staining of different receptors in pFN210A and pFN210A-Rho-tag.
    IL-6–HaloTag®–receptor Rho-tag–HaloTag®–receptor
Receptora EC50 [µM] Efficacyb Cell surface 
expressionc
EC50 [µM] Efficacyb Cell surface 
expressionc
OR1A1 7.66 ± 4.75 1.00 9.93 ± 2.76 30.61 ± 4.29 0.65 ± 0.13 2.00 ± 0.73
OR2M3 1.08 ± 1.16 1.00 22.73 ± 6.95 n.d. 0.30 ± 0.14 4.13 ± 0.31
OR2W1 26.95 ± 1.37 1.00 12.30 ± 3.36 n.d. 0.13 ± 0.21 3.08 ± 1.31
OR8D1 1.81 ± 0.19 1.00 15.58 ± 3.96 7.74 ± 0.90 0.20 ± 0.06 5.37 ± 2.21
OR10J5 16.32 ± 1.05 1.00 6.60 ± 3.14 n.d. 0.05 ± 0.02 3.93 ± 1.74
OR51E1 95.59 ± 33.39 1.00 9.44 ± 2.23 < 1000 0.14 ± 0.05 2.41 ± 1.62
Olfr16 33.99 ± 2.21 1.00 11.28 ± 2.47 7.07 ± 6.26 0.11 ± 0.04 3.73 ± 1.84
DRD1d 1.51 ± 0.28 1.00 56.57 ± 9.84 20.00 ± 1.49 0.48 ± 0.11 4.40 ± 2.57
aOfficial gene symbols. bnormalized to each receptor maximum with N-terminal tag IL-6-HaloTag®. cCell surface expression is given as % of cells with a 
mock-corrected, cell surface-bound Alexa488 signal of a total of 10000 analyzed cells per receptor. dEC50 values in [nM]. Data are given as mean ± SD 
(n = 3–8). n.d. means no response detected up to 1000 µM.
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Figure 3. Analysis of the cell surface expression of investigated ORs with both N-terminal tags. A. Flow cytometry analysis of transiently trans-
fected NxG 108CC15 cells showing a detectable fluorescence of membrane-impermeable HaloTag® Ligand-Alexa488, suggesting different cell surface 
expression of ORs carrying different N-terminal tags. Data are means ± SD (n = 3–6). Mock, empty plasmid control. *P < 0.05 as compared to Rho-tag-
HaloTag®. B. Differences averaged over all tested ORs, carrying either the IL-6-HaloTag® (red bar), or the Rho-tag-HaloTag® (blue bar), and normalized 
to the Rho-tag-HaloTag® ORs. *P < 0.05 as compared to Rho-tag-HaloTag®. C. Fluorescence confocal image of NxG 108CC15 cells expressing IL-6-
HaloTag®-OR8D1, labeled with membrane-impermeable HaloTag® Ligand-Alexa488, and treated with endocytosis blocker Dynasore. D. Fluorescence 
confocal image of NxG 108CC15 cells expressing IL-6-HaloTag®-OR8D1, labeled with membrane-impermeable HaloTag® Ligand-Alexa488, but without 
endocytosis blocker Dynasore.
We observed cell surface expression across all tested ORs on average 
in about 13% of NxG 108CC15 cells (red dashed line in Fig. 3A). In 
contrast, we observed cell surface expression of DRD1 in about 57% of 
cells (Fig. 3A). The transfection efficiency across all ORs consistently 
was 30% in NxG 108CC15 cells (data not shown). Blocking a clath-
rin-dependent endocytosis by Dynasore, we observed membrane-imper-
meable HaloTag® Ligand-Alexa488-dependent fluorescence, typically 
accumulated in cell surface clusters (Fig. 3C). In contrast, under control 
conditions, where a clathrin-dependent endocytosis was not blocked, 
a membrane-impermeable HaloTag® Ligand-Alexa488-dependent 
fluorescence typically accumulated within cells, presumably in endo-
somes (Fig. 3D). Flow cytometry revealed that cells from these two 
experimental conditions segregated with respect to their fluorescence 
intensity distributions, with endocytosis-blocked cells shifting to higher 
fluorescence intensities (Fig. S3E, Table S6).
J Biol Methods  | 2017 | Vol. 4(4) | e81 7
POL Scientific
ARTICLE
Figure 4. The influence of accessory proteins on the OR 
cAMP signaling in NxG 108CC15 cells. Flow cytometry 
analysis of the cell surface expression of investigated ORs 
(A). The data represent the percentage of NxG 108CC15 tran-
siently transfected cells with a detectable membrane-imper-
meable HaloTag® Ligand-Alexa488-dependent fluorescence, 
suggesting cell surface expression of OR, as determined by 
flow cytometry. Red bars indicate the transfection with all 
accessory proteins and blue bars indicate the transfection 
without (w/o) RTP1S and Gγ13. Shown are mean ± SD (n 
= 3–6). Mock, empty plasmid control. cAMP-luminescence 
measurements of  OR1A1 with (R)-(-)-carvone (1000 µM) 
(B), OR2M3 with 3-mercapto-2-methylpentan-1-ol (60 µM) 
(C), OR2W1 with allyl phenyl acetate (300 µM) (D), OR8D1 
with sotolone (300 µM) (E), OR10J5 with lyral (300 µM) 
(F), OR51E1 with butyric acid (300 µM) (G), Olfr16 with 
lyral (300 µM) (H), and  DRD1 with dopamine (10 nM) (I). 
All receptors were tagged with IL-6-HaloTag®. Data were 
normalized to each receptor with co-transfection of RTP1S 
and Gγ13. Shown are mean ± SD (n = 3). Black bars are 
receptor responses in the presence of RTP1S and Gγ13, 
and grey bars indicate empty plasmid control (Mock). *P < 
0.05 as compared to receptor responses in the presence 
of RTP1S and Gγ13.
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Accessory proteins influence the cell-surface expres-
sion of ORs
Earlier studies have shown that RTP1S, Ric8b and Gαolf induce the 
highest functional expression of ORs when combined with Rho-tag [10]. 
Further, Gγ13 was shown to be important for the functional formation of 
the heterotrimeric olfactory G-protein [26]. Therefore, we investigated 
if IL-6-HaloTag® could also work synergistically with the accessory 
proteins RTP1S and Gγ13. For our tests, we used the IL-6-HaloTag® 
tagged ORs and co-transfected them with Gαolf. RTP1S and Gγ13 
were transfected either individually or co-transfected for luminescence 
measurements. To investigate the cell surface expression, RTP1S and 
Gγ13 were co-transfected. Both, the cell-surface as well as the cAMP 
signaling-dependent luminescence measurements revealed that the 
accessory proteins RTP1S and Gγ13 differentially and receptor-de-
pendently influenced receptor responses and cell surface expression. 
The presence of RTP1S and Gγ13 resulted in a significantly higher cell 
surface expression for OR2M3, OR8D1, OR10J5, and Olfr16, with no 
effect on OR1A1, OR2W1, OR51E1, or DRD1 (Fig. 4A).
OR1A1, activated by (R)-(-)-carvone, showed only a slight but 
significant decrease in receptor response, if either RTP1S or Gγ13, 
or both were absent (Fig. 4B). In contrast, the OR2M3 response to 
3-mercapto-2-methylpentan-1-ol was almost non-detectable without 
RTP1S, whereas the absence of Gγ13 had no impact (Fig. 4C). Similar 
effects were observed for OR2W1 with allyl phenyl acetate (Fig. 4D), 
for OR8D1 with sotolone (Fig. 4E), for OR10J5 with lyral (Fig. 4F), 
as well as for mouse Olfr16 with lyral [29] (Fig. 4H). The absence of 
RTP1S had no impact on the butyric acid function of OR51E1 (Fig. 4G), 
or the dopamine function of DRD1 (Fig. 4I), whereas the absence of 
Gγ13 even appeared to enhance the response amplitude of both receptors.
OR1A1 and OR2W1 respond best to allyl phenyl ace-
tate among human ORs
To identify cognate human odorant receptors for the odorant allyl 
phenyl acetate, we screened this compound at 100 µM against 579 
human OR variants carrying the N-terminal IL-6-HaloTag®. Notably, 
allyl phenyl acetate best activated OR1A1 and OR2W1 (Fig. 5), which 
both have been shown to respond to this compound [6,30].
Figure 5. Allyl phenyl acetate at 100 µM activates two receptors out of 579 odorant receptor variants. Screening of allyl phenyl acetate (100 µM) 
against 579 OR variants in NxG 108CC15 cells. Data (n = 1 in duplicates) were normalized to the maximum responding OR (OR1A1). OR families are 
color-coded and sorted in ascending numerical order. Dashed lines indicate 2- and 3σ-thresholds. Mock, empty plasmid control.
DISCUSSION
The testing of ORs in recombinant cell systems so far has been chal-
lenged by the ORs’ poor expression at the cell surface and sub-optimal 
signaling, as compared to non-olfactory GPCRs. Moreover, some ORs 
are more efficiently trafficked to the cell surface than others [19], which 
we observed, too, in our present study. Here, we report that the intro-
duction of the bi-functional N-terminal IL-6-HaloTag® outperforms the 
Rho-tag-HaloTag® in terms of cell surface expression of all investigated 
ORs, and also outperforms commonly used Rho-tag in terms of signaling 
of six out of seven investigated ORs, in both HEK-293 cells, as well as 
in the neuroblastoma x glioma NxG 108CC15 cell line. Moreover, both 
the cell surface expression as well as the potency of dopamine-induced 
signaling of non-olfactory receptor DRD1 improved significantly in 
the presence of the N-terminal IL-6-HaloTag®, as compared to the 
Rho-tag-HaloTag®. However, with DRD1 and OR2M3, the N-terminal 
Rho-tag alone outperformed all other tested tags in the GloSensorTM 
cAMP assay (Fig. S2C, I). Here, the bulky HaloTag® (33 kDa) may 
restrain the interaction of the agonist with its receptor.
We did not show membrane staining for the Rho-tag constructs since 
this would have required antibody staining of paraformaldehyde-fixed 
cells, which may partially permeabilize cells, and thus would not have 
been comparable with the live-cell plasma membrane staining of IL-6-
HaloTag®-ORs. However, just by exchanging the Rho-tag by IL-6 in the 
Halo-tagged ORs, our flow cytometry experiments suggest IL-6 as the 
by far more powerful determinant for a cell surface expression of ORs.
Under non-stimulated conditions, IL-6-HaloTag®-ORs labeled with 
membrane-impermeable HaloTag® Ligand-Alexa488 accumulated 
within cells, suggesting homeostatic endocytosis of cell surface-labeled 
receptors into endosomes, which was prevented in the presence of Dy-
nasore, a blocker of clathrin-dependent endocytosis. Here, we observed 
a clustered cell surface staining, suggesting a plasma membrane accu-
mulation of IL-6-HaloTag®-ORs labeled with membrane-impermeable 
HaloTag® Ligand-Alexa488. Our experiments show that IL-6-HaloTag® 
may be suitable to track the endocytosis of cell surface-labeled ORs, 
to investigate, for instance, endocytosis of odorant-stimulated ORs.
As reported previously, RTP1S has a chaperone function to promote 
the surface expression of some ORs, even in the absence of Ric-8b 
and Gαolf [8,10]. In our hands, RTP1S had a significant impact on the 
plasma membrane expression of only 4 out of 7 tested ORs carrying the 
N-terminal IL-6-HaloTag®. In contrast, 6 out of 7 tested ORs carrying 
the N-terminal IL-6-HaloTag® showed a significantly reduced signaling 
in the absence of RTP1S, using the GloSensorTM cAMP assay. This 
suggests that an increased cell surface expression of ORs by the N-ter-
minal IL-6-HaloTag® supersedes the chaperone function of RTP1S, at 
least for some ORs, and/or the function of RTP1S is rather to facilitate 
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cAMP signaling than chaperoning of ORs. Further studies are required 
to understand the plasma membrane trafficking of ORs.
In summary, our study shows that the use of the N-terminal IL-6-
HaloTag® on ORs largely improves their functional expression in different 
test cell systems, using flow cytometry and the fast, online GloSensorTM 
cAMP assay. Both methods are described in detail by Noe et al [31]. This 
experimental strategy may facilitate the de-orphaning of ORs, and thus 
will lead to an understanding of odorant coding at the receptor level.
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